These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 10880395)

  • 21. Whole genome and transcriptome sequencing of a B3 thymoma.
    Petrini I; Rajan A; Pham T; Voeller D; Davis S; Gao J; Wang Y; Giaccone G
    PLoS One; 2013; 8(4):e60572. PubMed ID: 23577124
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical and pathological aspects of thymic epithelial tumors.
    Okumura M; Shiono H; Minami M; Inoue M; Utsumi T; Kadota Y; Sawa Y
    Gen Thorac Cardiovasc Surg; 2008 Jan; 56(1):10-6. PubMed ID: 18213465
    [TBL] [Abstract][Full Text] [Related]  

  • 23. p16INK4, pRB, p53 and cyclin D1 expression and hypermethylation of CDKN2 gene in thymoma and thymic carcinoma.
    Hirabayashi H; Fujii Y; Sakaguchi M; Tanaka H; Yoon HE; Komoto Y; Inoue M; Miyoshi S; Matsuda H
    Int J Cancer; 1997 Nov; 73(5):639-44. PubMed ID: 9398039
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low prevalence of Merkel cell polyomavirus in human epithelial thymic tumors.
    Chteinberg E; Klufah F; Rennspiess D; Mannheims MF; Abdul-Hamid MA; Losen M; Keijzers M; De Baets MH; Kurz AK; Zur Hausen A
    Thorac Cancer; 2019 Mar; 10(3):445-451. PubMed ID: 30628176
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aberrant methylation of tumour-related genes in thymic epithelial tumours.
    Hirose Y; Kondo K; Takizawa H; Nagao T; Nakagawa Y; Fujino H; Toba H; Kenzaki K; Sakiyama S; Tangoku A
    Lung Cancer; 2009 May; 64(2):155-9. PubMed ID: 18778870
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thymic epithelial tumors can develop along two different pathogenetic pathways.
    Zhou R; Zettl A; Ströbel P; Wagner K; Müller-Hermelink HK; Zhang S; Marx A; Starostik P
    Am J Pathol; 2001 Nov; 159(5):1853-60. PubMed ID: 11696445
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pseudodicentric (16;12)(q11;p11.2) in a type AB (mixed) thymoma.
    Goh SG; Lau LC; Sivaswaren C; Chuah KL; Tan PH; Lai D
    Cancer Genet Cytogenet; 2001 Nov; 131(1):42-7. PubMed ID: 11734317
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The MIC2 antibody 013. Practical application for the study of thymic epithelial tumors.
    Chan JK; Tsang WY; Seneviratne S; Pau MY
    Am J Surg Pathol; 1995 Oct; 19(10):1115-23. PubMed ID: 7573670
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular genetic characteristics of thymic epithelial tumors with distinct histological subtypes.
    Yang J; Zhang B; Guan W; Fan Z; Pu X; Zhao L; Jiang W; Cai W; Quan X; Miao S; Nie L; He L
    Cancer Med; 2023 May; 12(9):10575-10586. PubMed ID: 36916520
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnostic significance of cell kinetic parameters in World Health Organization type A and B3 thymomas and thymic carcinomas.
    Roden AC; Yi ES; Jenkins SM; Donovan JL; Cassivi SD; Garces YI; Marks RS; Aubry MC
    Hum Pathol; 2015 Jan; 46(1):17-25. PubMed ID: 25455993
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oncogenetic tree models based on cytogenetic data: new insights into the development of epithelial tumors of the thymus.
    Rieker RJ; Penzel R; Aulmann S; Blaeker H; Morresi-Hauf A; Hecker E; Otto HF; Mechtersheimer G; von Heydebreck A
    Cancer Genet Cytogenet; 2005 Apr; 158(1):75-80. PubMed ID: 15771909
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytokeratins in normal thymus and thymic epithelial tumors.
    Fukai I; Masaoka A; Hashimoto T; Yamakawa Y; Mizuno T; Tanamura O
    Cancer; 1993 Jan; 71(1):99-105. PubMed ID: 7677978
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aberrant methylation: common in thymic carcinomas, rare in thymomas.
    Suzuki M; Chen H; Shigematsu H; Ando S; Iida T; Nakajima T; Fujisawa T; Kimura H
    Oncol Rep; 2005 Dec; 14(6):1621-4. PubMed ID: 16273266
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of apoptosis-related markers and HER-2/neu in thymic epithelial tumours.
    Pan CC; Chen PC; Wang LS; Lee JY; Chiang H
    Histopathology; 2003 Aug; 43(2):165-72. PubMed ID: 12877732
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mutational status of EGFR and KIT in thymoma and thymic carcinoma.
    Yoh K; Nishiwaki Y; Ishii G; Goto K; Kubota K; Ohmatsu H; Niho S; Nagai K; Saijo N
    Lung Cancer; 2008 Dec; 62(3):316-20. PubMed ID: 18448188
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Thymoma and thymic carcinoma--review of literature and clinical characteristics based on the Polish Paediatric Solid Tumours Study Group experience].
    Stachowicz-Stencel T; Bień E; Balcerska A; Godziński J; Madziara W; Perek-Polnik M; Peregud-Pogorzelski J; Pietras W; Pobudejska A; Kurylak A; Mańkowski P
    Med Wieku Rozwoj; 2007; 11(3 Pt 2):313-8. PubMed ID: 18663273
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PD-L1 expression level in different thymoma stages and thymic carcinoma: a meta-analysis.
    Chen HF; Wu LX; Li XF; Zhu YC; Pan WW; Wang WX; Xu CW; Huang JH; Wu MH; Du KQ
    Tumori; 2020 Aug; 106(4):306-311. PubMed ID: 32366210
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Loss of p16
    Aesif SW; Aubry MC; Yi ES; Kloft-Nelson SM; Jenkins SM; Spears GM; Greipp PT; Sukov WR; Roden AC
    J Thorac Oncol; 2017 May; 12(5):860-871. PubMed ID: 28179162
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression and mutation statuses of epidermal growth factor receptor in thymic epithelial tumors.
    Suzuki E; Sasaki H; Kawano O; Endo K; Haneda H; Yukiue H; Kobayashi Y; Yano M; Fujii Y
    Jpn J Clin Oncol; 2006 Jun; 36(6):351-6. PubMed ID: 16762968
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of
    Masunaga A; Omatsu M; Kunimura T; Uematsu S; Kamio Y; Kitami A; Miyagi Y; Hiroshima K; Suzuki T
    J Clin Pathol; 2017 Aug; 70(8):690-696. PubMed ID: 28119349
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.